The findings from this study provide further support that the immune response to HIV is an important factor in determining the rate of HIV-mediated disease progression, commented Anthony S. Fauci, M.D., NIAID director.In the study, the differential effects of these genes on disease prognosis became apparent within three to four years after seroconversion to HIV-1.